These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26515290)

  • 21. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse astrocytoma arising within a demyelinating plaque.
    Ormond DR; Kleinschmidt-DeMasters BK
    J Neurooncol; 2016 Jun; 128(2):373-5. PubMed ID: 27033061
    [No Abstract]   [Full Text] [Related]  

  • 23. Resting state networks change in clinically isolated syndrome.
    Roosendaal SD; Schoonheim MM; Hulst HE; Sanz-Arigita EJ; Smith SM; Geurts JJ; Barkhof F
    Brain; 2010 Jun; 133(Pt 6):1612-21. PubMed ID: 20356855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe demyelinating diseases in childhood: a clinicopathological study.
    Adams JM
    J Natl Med Assoc; 1978 Mar; 70(3):171-8. PubMed ID: 691079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinsonism and multiple sclerosis--is there association?
    Barun B; Brinar VV; Zadro I; Lusić I; Radović D; Habek M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):958-61. PubMed ID: 18482794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Astrocytoma grade II. Atypical image].
    Spadaro E; Migliacci ML; Romano LM; Zoppi J
    Medicina (B Aires); 2008; 68(4):305. PubMed ID: 18786888
    [No Abstract]   [Full Text] [Related]  

  • 29. Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting dinical course.
    Moore GR; Berry K; Oger JJ; Prout AJ; Graeb DA; Nugent RA
    Mult Scler; 2001 Dec; 7(6):375-82. PubMed ID: 11795459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Demyelinating lesions in cervical spinal cord and disability in multiple sclerosis patients].
    Bonek R; Sokólska E; Kurkiewicz T; Maciejek Z
    Neurol Neurochir Pol; 2004; 38(1):25-9. PubMed ID: 15049165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrograde retinal damage after acute optic tract lesion in MS.
    Gabilondo I; Sepúlveda M; Ortiz-Perez S; Fraga-Pumar E; Martínez-Lapiscina EH; Llufriu S; Solá N; Saiz A; Sanchez-Dalmau B; Villoslada P
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):824-6. PubMed ID: 23715916
    [No Abstract]   [Full Text] [Related]  

  • 32. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliomatous transformation and demyelinating diseases.
    Anderson M; Hughes B; Jefferson M; Smith WT; Waterhouse JA
    Brain; 1980 Sep; 103(3):603-22. PubMed ID: 7417780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis.
    Branton WG; Lu JQ; Surette MG; Holt RA; Lind J; Laman JD; Power C
    Sci Rep; 2016 Nov; 6():37344. PubMed ID: 27892518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demyelination in the brain as a paraneoplastic disorder: candidates include some cases of seminoma and central nervous system lymphoma.
    Jaster JH; Dohan FC; O'Brien TF
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):352. PubMed ID: 12185190
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical subtypes of multiple sclerosis and the immuno-pathogeneses].
    Fujihara K
    Nihon Rinsho; 2003 Aug; 61(8):1293-9. PubMed ID: 12962014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute demyelinating events with rhombencephalitis: a high-risk subgroup in children.
    Tirupathi S; Lynch N; Phelan E; Mc Menamin J; Webb D
    Eur J Paediatr Neurol; 2008 Mar; 12(2):137-40. PubMed ID: 17897850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoimmunologic aspects of demyelinating encephalitides].
    Seitelberger F
    Nervenarzt; 1967 Dec; 38(12):525-35. PubMed ID: 6082169
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation.
    Lu JQ; Joseph JT; Nash RA; Storek J; Stevens AM; Metz LM; Clark AW; Johnson ES; Yong VW
    Arch Neurol; 2010 Jun; 67(6):716-22. PubMed ID: 20558390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
    Ayrignac X; Carra-Dalliere C; Homeyer P; Labauge P
    Acta Neurol Belg; 2013 Dec; 113(4):533-4. PubMed ID: 23358965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.